Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “AMR”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05156710
What this trial is testing

BIVV020 (SAR445088) in Prevention and Treatment of Antibody-mediated Rejection (AMR)

Who this might be right for
Transplant Rejection
Sanofi 48
Testing effectiveness (Phase 2)Study completedNCT00375193
What this trial is testing

Study of Amrubicin in Patients With Small Cell Lung Cancer Refractory or Progressive to Prior Therapy

Who this might be right for
Small Cell Lung Cancer
Celgene 75
Large-scale testing (Phase 3)Study completedNCT00547651
What this trial is testing

AMR PH GL 2007 CL001 Phase 3 Trial in Patients With Small Cell Lung Cancer After Failure of First-Line Chemotherapy

Who this might be right for
Small Cell Lung Cancer
Celgene 637
Not applicableNot Yet RecruitingNCT07718308
What this trial is testing

CD38 mAb Induction + Azathioprine Maintenance for Chronic Active AMR in Kidney Transplant Recipients

Who this might be right for
Kidney TransplantationAntibody-mediated Rejection
wujianyong 20
Testing effectiveness (Phase 2)WithdrawnNCT03805178
What this trial is testing

Lung Transplant Plasmapheresis/Belatacept/Carfilzomib for Antibody Mediated Rejection and Desensitization

Who this might be right for
Lung Transplant RejectionAntibody-mediated Rejection
Duke University
Not applicableEnrolling By InvitationNCT07626073
What this trial is testing

Prospective Study of Multi-centers Exploring the Difference of Clinical Impact by Using Respiratory Pathogen ID/AMR Panel (RPIP) Versus Untarget Metagenomic Next-generation Sequencing (mNGS) and Multiplex PCR in Pathogen Identification of Pneumonia Patients in Intensive Care Unit

Who this might be right for
Respiratory Pathogens
China Medical University Hospital 200
Not applicableUnknownNCT03622177
What this trial is testing

Role of the IL33/Amphiregulin Pathway as a Potential Therapeutic Target in HIV Infection

Who this might be right for
HIV I Infection
ANRS, Emerging Infectious Diseases 180
Testing effectiveness (Phase 2)Ended earlyNCT01095887
What this trial is testing

Eculizumab to Prevent Antibody-mediated Rejection in ABO Blood Group Incompatible Living Donor Kidney Transplantation

Who this might be right for
Kidney Transplant
Mayo Clinic 6
Testing effectiveness (Phase 2)Study completedNCT01364727
What this trial is testing

Amrubicin in Relapsed or Refractory Thymic Malignancies

Who this might be right for
ThymomaThymus CancerThymic Carcinoma
Heather Wakelee 33
Testing effectiveness (Phase 2)UnknownNCT02563340
What this trial is testing

Effect of BM-MSCs on Chronic AMR After Kidney Transplantation

Who this might be right for
Kidney Transplantation
First Affiliated Hospital, Sun Yat-Sen University 60
Testing effectiveness (Phase 2)Study completedNCT00388960
What this trial is testing

Study of Amrubicin With or Without Cisplatin Versus Etoposide-cisplatin for Extensive Stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Celgene 99
Large-scale testing (Phase 3)Looking for participantsNCT07365241
What this trial is testing

Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
AbbVie 531
Large-scale testing (Phase 3)Study completedNCT01207011
What this trial is testing

Amrubicin (AMR) Trial in Patients With Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Sumitomo Pharma Co., Ltd. 202
Not applicableActive Not RecruitingNCT06824129
What this trial is testing

Clinical Performance Evaluation of the QIAstat-Dx® cUTI Plus AMR

Who this might be right for
Complicated Urinary Tract Infection
QIAGEN Gaithersburg, Inc 1,500
Large-scale testing (Phase 3)Active Not RecruitingNCT06685757
What this trial is testing

Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Kidney Transplants Who Have Antibody-Mediated Rejection (AMR)

Who this might be right for
Antibody-mediated Rejection
Biogen 132
Testing effectiveness (Phase 2)Ended earlyNCT01630538
What this trial is testing

Cyclophosphamide Therapy for Refractory Antibody-Mediated Rejection (AMR) in Kidney Transplants

Who this might be right for
Antibody Mediated Rejection
University of Manitoba 4
Not applicableStudy completedNCT03855215
What this trial is testing

Implementation of CRP Point of Care Testing in Primary Care to Improve Antibiotic Targeting in Respiratory Illness (ICAT)

Who this might be right for
Acute Respiratory Infection
Oxford University Clinical Research Unit, Vietnam 2,606
Testing effectiveness (Phase 2)Study completedNCT01259375
What this trial is testing

Amrubicin Chemotherapy as First Line in Metastatic or Unresectable Soft Tissue Sarcoma

Who this might be right for
Soft Tissue Sarcoma
University of Utah 24
Not applicableUnknownNCT04095988
What this trial is testing

Allogeneic Microbiota-reconstitution (AMR) in Diarrhea-predominant Irritable Bowel Syndrome (IBS-D)

Who this might be right for
Diarrhea-predominant Irritable Bowel Syndrome
University of Ulm 42
Not applicableLooking for participantsNCT06262009
What this trial is testing

Dynamics of AMR Spread, Persistence and Evolution Between Humans, Animals and Their Environment

Who this might be right for
Antibiotic Resistant StrainTransmission, Close-Contact
Assistance Publique - Hôpitaux de Paris 525
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation